| Titan Pharmaceuticals Reborn: What Lies Ahead? VFC submits: Titan Pharmaceuticals (TTNP.OB) commenced trading on the OTC Bulletin Board on Wednesday under the symbol TTNP.OB, after the Financial Industry Regulatory Authority [FINRA] approved the move. Titan's first day on the new board was uneventful as the share price traded sideways throughout the day as the move was largely expected.The OTCBB is a step up for the suddenly re-born Titan Pharmaceuticals, but the more significant news may have been the note in Wednesday's press release regarding the Probuphine patent.Complete Story » seekingalpha.com |
Amyris Adds Muscle Prior to Going Public to Reassure Investors The Burrill Report submits: By Marie DaghlianRenewable fuels and chemicals developer Amyris (AMRS) is determined to avoid the fate of recent U.S energy IPOs. This week Emeryville, California-based Amyris announced a series of deals, including a partnership and $132.2 million equity investment by French oil company Total (TOT), aimed at shoring up its position ahead of an initial public offering. The company also reincorporated as Amyris Inc. after seven years operating as Amyris Biotechnologies. Complete Story » seekingalpha.com |
Trident & Smiles Across America - Video More Than One Million Sealants Delivered to Date but Survey Reveals Parents Still Underestimate the Impact of Tooth Decay feedproxy.google.com |
Ironwood, Forest boast positive IBS drug trial [AP] - Late-stage clinical trials on the safety and efficacy of a drug for treating irritable bowel syndrome accompanied with constipation have produced positive results, the two companies developing the drug said Monday. us.rd.yahoo.com |
Insight Imaging Completes Sale of Seven Imaging Centers [Business Wire] - InSight Health Services Holdings Corp. today announced that it has completed the previously announced sale of seven imaging centers. Six centers were located in El Paso, Texas and Las Cruces, New Mexico and one imaging center in California. us.rd.yahoo.com |